PubRank

A F Dominiczak

Author PubWeight™ 80.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997 3.89
2 Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 2007 3.17
3 Better blood pressure control: how to combine drugs. J Hum Hypertens 2003 2.19
4 Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 2001 1.97
5 Families of patients with premature coronary heart disease: an obvious but neglected target for primary prevention. BMJ 2007 1.63
6 Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 2000 1.54
7 Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 1999 1.44
8 Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol 2001 1.41
9 Endothelial function in hypertension: the role of superoxide anion. Hypertension 1999 1.33
10 Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet 1997 1.18
11 Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 1995 1.17
12 Estrogen status affects sensitivity to focal cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2000 1.13
13 Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus. Mol Ther 2001 1.08
14 Blood pressure in genetically hypertensive rats. Influence of the Y chromosome. Hypertension 1995 1.05
15 Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens 2001 1.04
16 Cellular aspects of vascular remodeling in hypertension revealed by confocal microscopy. Hypertension 1997 1.04
17 Brain aromatase expression after experimental stroke: topography and time course. J Steroid Biochem Mol Biol 2005 1.01
18 Quantitative trait loci in genetically hypertensive rats. Possible sex specificity. Hypertension 1996 1.01
19 Characterization of the microglial response to cerebral ischemia in the stroke-prone spontaneously hypertensive rat. Hypertension 2001 0.98
20 Genetic and gender influences on sensitivity to focal cerebral ischemia in the stroke-prone spontaneously hypertensive rat. Hypertension 1999 0.98
21 Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension. Gene Ther 2002 0.95
22 Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults. Circulation 1996 0.94
23 Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes 2000 0.94
24 Cellular changes induced by chronic nitric oxide inhibition in intact rat basilar arteries revealed by confocal microscopy. J Hypertens 1997 0.93
25 Pathophysiology of the vasculature in hypertension. Hypertension 1991 0.92
26 Cerebral small vessel endothelial structural changes predate hypertension in stroke-prone spontaneously hypertensive rats: a blinded, controlled immunohistochemical study of 5- to 21-week-old rats. Neuropathol Appl Neurobiol 2011 0.92
27 Applicability of a "speed" congenic strategy to dissect blood pressure quantitative trait loci on rat chromosome 2. Hypertension 2000 0.92
28 Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease. Kidney Int 1991 0.92
29 Confocal microscopic characterization of a lesion in a cerebral vessel of the stroke-prone spontaneously hypertensive rat. Stroke 1996 0.91
30 Susceptibility to cerebral infarction in the stroke-prone spontaneously hypertensive rat is inherited as a dominant trait. Stroke 1998 0.90
31 Heritability of chronic pain in 2195 extended families. Eur J Pain 2012 0.90
32 Investigation of estrogen status and increased stroke sensitivity on cerebral blood flow after a focal ischemic insult. J Cereb Blood Flow Metab 2000 0.90
33 Impaired functional recovery after stroke in the stroke-prone spontaneously hypertensive rat. Stroke 2004 0.90
34 Analysis of cell-specific promoters for viral gene therapy targeted at the vascular endothelium. Hypertension 2001 0.90
35 Effects of nitric oxide and superoxide on relaxation in human artery and vein. Atherosclerosis 1997 0.88
36 Phenotypic consequences of variation across the aldosterone synthase and 11-beta hydroxylase locus in a hypertensive cohort: data from the MRC BRIGHT Study. Clin Endocrinol (Oxf) 2007 0.87
37 Vascular function in patients with end-stage renal disease and/or coronary artery disease: a cardiac magnetic resonance imaging study. Kidney Int 2006 0.87
38 Sex differences in the abundance of endothelial nitric oxide in a model of genetic hypertension. Hypertension 1997 0.87
39 Reciprocal consomic strains to evaluate y chromosome effects. Hypertension 2001 0.86
40 Telemetry for cardiovascular monitoring in a pharmacological study: new approaches to data analysis. Hypertension 1999 0.86
41 Endothelial FOS expression and pre-eclampsia. BJOG 2012 0.86
42 Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo. Am J Physiol 1998 0.85
43 Sex hormones induce insulin resistance in 3T3-L1 adipocytes by reducing cellular content of IRS proteins. Diabetologia 2000 0.85
44 Optimized protocols for typing 75 microsatellite loci in AS, PVG, F344, and BN rats. Mamm Genome 1995 0.84
45 Genes encoding atrial and brain natriuretic peptides as candidates for sensitivity to brain ischemia in stroke-prone hypertensive rats. Hypertension 1999 0.83
46 Skeletal muscle of stroke-prone spontaneously hypertensive rats exhibits reduced insulin-stimulated glucose transport and elevated levels of caveolin and flotillin. Diabetes 2001 0.83
47 DNA synthesis and apoptosis in smooth muscle cells from a model of genetic hypertension. Hypertension 2000 0.83
48 Renin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease. Heart 2001 0.83
49 Gene transfer of endothelial nitric oxide synthase improves nitric oxide-dependent endothelial function in a hypertensive rat model. Cardiovasc Res 1999 0.83
50 Gene transfer of endothelial nitric oxide synthase but not Cu/Zn superoxide dismutase restores nitric oxide availability in the SHRSP. Cardiovasc Res 2000 0.82
51 Is hydrogen peroxide an EDHF in human radial arteries? Am J Physiol Heart Circ Physiol 2001 0.82
52 Increased Na(+)/H(+) exchanger isoform 1 activity in spontaneously hypertensive rats: lack of mutations within the coding region of NHE1. Biochim Biophys Acta 2000 0.81
53 Oxidized-LDL induced changes in membrane physico-chemical properties and [Ca2+]i of bovine aortic endothelial cells. Influence of vitamin E. Atherosclerosis 1995 0.81
54 Cell membrane abnormalities and the regulation of intracellular calcium concentration in hypertension. Clin Sci (Lond) 1990 0.81
55 Cobalt contraction of vascular smooth muscle is calcium dependent. J Cardiovasc Pharmacol 1994 0.80
56 Altered Na+-K+ pump activity and plasma lipids in salt-hypertensive Dahl rats: relationship to Atp1a1 gene. Physiol Genomics 2001 0.80
57 Identification of a common low density lipoprotein receptor mutation (C163Y) in the west of Scotland. J Med Genet 1998 0.80
58 Inducible L-arginine/nitric oxide pathway in human internal mammary artery and saphenous vein. Am J Physiol 1995 0.80
59 Membrane microviscosity does not correlate with blood pressure: a cosegregation study. J Hypertens 1993 0.79
60 Radial artery hypertrophy occurs in coronary atherosclerosis and is independent of blood pressure. Clin Sci (Lond) 2001 0.79
61 Vascular smooth muscle polyploidy in genetic hypertension: the role of angiotensin II. J Hum Hypertens 1995 0.78
62 LB01.03: INCIDENCE AND PROGNOSIS OF CANCER ASSOCIATED WITH DIGOXIN AND COMMON ANTIHYPERTENSIVE DRUGS. J Hypertens 2015 0.78
63 The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats. J Hypertens 1995 0.78
64 Genetics of hypertension: from experimental models to clinical applications. J Hum Hypertens 2001 0.78
65 Does potassium channel opening contribute to endothelium-dependent relaxation in human internal thoracic artery? Clin Sci (Lond) 1999 0.77
66 A comparison of calcium pentagastrin and TRH tests in screening for medullary carcinoma of the thyroid in MEN IIA. Clin Endocrinol (Oxf) 1990 0.77
67 Pharmacological characterisation of endothelium-dependent relaxation in human radial artery: comparison with internal thoracic artery. Cardiovasc Res 1999 0.77
68 Estrogen effects on nitric oxide release. Hypertension 1997 0.77
69 Renal artery stenosis managed by Palmaz stent insertion: technical and clinical outcome. J Hypertens 1995 0.77
70 Vasorelaxant properties of isolated human internal mammary arteries and saphenous veins: comparative effects of milrinone and sodium nitroprusside. J Cardiovasc Pharmacol 1993 0.77
71 Insulin resistance, hypertension and the insulin-responsive glucose transporter, GLUT4. Clin Sci (Lond) 1995 0.77
72 Is estradiol cardioprotection a nitric oxide-mediated effect? Hum Reprod 2002 0.76
73 Reduced insulin-stimulated GLUT4 bioavailability in stroke-prone spontaneously hypertensive rats. Diabetologia 2005 0.76
74 Regulation of glucose transport in aortic smooth muscle cells by cAMP and cGMP. Biochem J 2001 0.76
75 Experimental hypertension. Hypertension 1991 0.76
76 Detection and treatment of renovascular disease: 40 years on. J Hypertens 1994 0.76
77 Different effects of antihypertensive agents on cardiac and vascular hypertrophy in the transgenic rat line TGR(mRen2)27. Am J Hypertens 1999 0.76
78 Decreased basal despite enhanced agonist-stimulated effects of nitric oxide in 12-week-old stroke-prone spontaneously hypertensive rat. Eur J Pharmacol 1999 0.76
79 Transluminal vascular stents for ostial atherosclerotic renal artery stenosis. Lancet 1995 0.75
80 CD36 deficiency and insulin resistance. Lancet 2001 0.75
81 Nitric oxide and cardiovascular disease. Postgrad Med J 1997 0.75
82 Insulin resistance and membrane abnormalities. Lancet 1995 0.75
83 Percutaneous transluminal renal angioplasty in the management of hypertension and renal failure in patients with renal artery stenosis. J Hum Hypertens 1993 0.75
84 Intravascular haemolysis and acute renal failure induced by nomifensine. Scott Med J 1986 0.75
85 [OP.7C.01] UROMODULIN-NACL INTERACTION ON MRNA EXPRESSION OF ION TRANSPORTERS IN ISOLATED TUBULES OF UMOD+/+ AND UMOD-/- MICE. J Hypertens 2016 0.75
86 Mapping and sequencing rat dishevelled-1: a candidate gene for cerebral ischaemic insult in a rat model of stroke. Neurogenetics 2001 0.75
87 LB03.07: ANTIHYPERTENSIVE THERAPY AND RISK OF ADMISSIONS FOR MOOD DISORDERS. J Hypertens 2015 0.75
88 Cardiovascular diseases and G-protein beta3 subunit gene (GNB3) in the era of genomewide scans. J Hum Hypertens 2003 0.75
89 Vasorelaxant properties of isolated human radial arteries: comparison with internal mammary arteries. Atherosclerosis 2002 0.75
90 Not the usual cause of superior vena cava obstruction. Scott Med J 2001 0.75
91 Chromosome 2 reciprocal congenic strains to evaluate the effect of the genetic background on blood pressure. Scott Med J 2002 0.75
92 [OP.4D.04] METABOLOMIC STUDY OF THE EFFECT OF UROMODULIN ON BIOCHEMICAL PATHWAYS IN THE KIDNEYS. J Hypertens 2016 0.75
93 Resection of phaeochromocytoma at 16-weeks gestation. Eur J Anaesthesiol 1998 0.75
94 Many membrane abnormalities in hypertension result from one primary defect. Adv Exp Med Biol 1991 0.75
95 LB02.06: CLINICAL IMPLICATIONS OF THE DIASTOLIC BLOOD PRESSURE 'J CURVE' IN TREATED HYPERTENSIVE PATIENTS. J Hypertens 2015 0.75
96 Analysis of the glucose transporter compliment of metabolically important tissues from the Milan hypertensive rat. Biochem Biophys Res Commun 1995 0.75
97 [OP.LB.02.07] BLOOD PRESSURE AND HEXADECANEDIOATE: DISSECTING FUNCTIONAL PATHWAYS. J Hypertens 2016 0.75
98 In vivo and in vitro studies of the role of HDL in platelet activation in normotensive and hypertensive subjects. J Hum Hypertens 1995 0.75
99 Sodium-lithium countertransport, sodium-hydrogen exchange and membrane microviscosity in patients with hyperlipidaemia. Clin Sci (Lond) 1997 0.75